Abstract 12851: Efficacy and Safety of Rilonacept in Recurrent Pericarditis: A Multicenter Phase 2 Clinical Trial

Allan L. Klein,David Lin,Paul Cremer,Saifullah Nasir,S. Allen Luis,Antonio Abbate,Asif Akhtar,Andrew Ertel,Martin M. LeWinter,Anna Beutler,John F. Paolini,Fang Fang,Steven. Chang,Larisa Collins,Randy Perrin,Kasia Warchol,Sharon Crugnale

Abstract 12851: Efficacy and Safety of Rilonacept in Recurrent Pericarditis: A Multicenter Phase 2 Clinical Trial

2019

Allan L. Klein
David Lin
Paul Cremer
Saifullah Nasir
S. Allen Luis
Antonio Abbate
Asif Akhtar
Andrew Ertel
Martin M. LeWinter
Anna Beutler
John F. Paolini
Fang Fang
Steven. Chang
Larisa Collins
Randy Perrin
Kasia Warchol
Sharon Crugnale

Introduction: Interleukin-1 (IL-1) mediates innate autoinflammation and is implicated in recurrent pericarditis (RP). We report final data from a Phase 2 study of rilonacept (IL-1α/IL-1β inhibitor)...

Keywords:

Phases of clinical research
Diabetes mellitus
Cardiology
Rilonacept
Clinical trial
Medicine
Internal medicine
Pericarditis
recurrent pericarditis

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations